CropTech has demonstrated that plants have surprising promise to provide large scale cost-effective production of complex bioactive recombinant proteins. Please look over our website for pictures, articles, and profiles. We are sure you will find it very exciting and promising. Contact us with any questions or comments. The Company's mission is to develop and commercialize the use of genetically engineered plants for production of high-valued proteins and biochemicals.
Several proteins produced by plants are already in clinical trials in the United States.
Carole Cramer and David Radin, who are experts in plant biotechnology and genetic engineering with the vision to exploit the advantages of tobacco and other plants as commercial bioproduction systems. Tobacco is an excellent candidate for commercialization effort because of its successful use as a laboratory model in plant molecular biology research, and its development as a fast-growing crop that has been optimized for biomass production. Moreover, there is a growing need for new uses of tobacco to support one of the largest cash crops in the southeastern United States. The Company s primary focus during its early stage years was to demonstrate that its inducible plant promoter could be used to drive production of commercially significant proteins in transgenic plants. This reduction of concept to practice meant that molecular biology procedures had to be worked out to efficiently place product genes of interest into the plant, the effectiveness of the inducible promoter had to be determined, and purification of high levels of biologically active protein had to be attained.